These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25559195)

  • 1. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.
    Takeda H; Wei Z; Koso H; Rust AG; Yew CC; Mann MB; Ward JM; Adams DJ; Copeland NG; Jenkins NA
    Nat Genet; 2015 Feb; 47(2):142-50. PubMed ID: 25559195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.
    Kodama T; Marian TA; Lee H; Kodama M; Li J; Parmacek MS; Jenkins NA; Copeland NG; Wei Z
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23625-23635. PubMed ID: 31690663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
    Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
    Rangel R; Lee SC; Hon-Kim Ban K; Guzman-Rojas L; Mann MB; Newberg JY; Kodama T; McNoe LA; Selvanesan L; Ward JM; Rust AG; Chin KY; Black MA; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7749-E7758. PubMed ID: 27849608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.
    Starr TK; Allaei R; Silverstein KA; Staggs RA; Sarver AL; Bergemann TL; Gupta M; O'Sullivan MG; Matise I; Dupuy AJ; Collier LS; Powers S; Oberg AL; Asmann YW; Thibodeau SN; Tessarollo L; Copeland NG; Jenkins NA; Cormier RT; Largaespada DA
    Science; 2009 Mar; 323(5922):1747-50. PubMed ID: 19251594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
    Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
    Aiderus A; Newberg JY; Guzman-Rojas L; Contreras-Sandoval AM; Meshey AL; Jones DJ; Amaya-Manzanares F; Rangel R; Ward JM; Lee SC; Ban KH; Rogers K; Rogers SM; Selvanesan L; McNoe LA; Copeland NG; Jenkins NA; Tsai KY; Black MA; Mann KM; Mann MB
    PLoS Genet; 2021 Aug; 17(8):e1009094. PubMed ID: 34398873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeping Beauty transposon mutagenesis in mouse intestinal organoids identifies genes involved in tumor progression and metastasis.
    Iida N; Muranaka Y; Park JW; Sekine S; Copeland NG; Jenkins NA; Shiraishi Y; Oshima M; Takeda H
    Cancer Gene Ther; 2024 Apr; 31(4):527-536. PubMed ID: 38177308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
    Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
    Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
    Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
    Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery.
    Moriarity BS; Largaespada DA
    Curr Opin Genet Dev; 2015 Feb; 30():66-72. PubMed ID: 26051241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
    Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer.
    Li Y; Bai L; Yu H; Cai D; Wang X; Huang B; Peng S; Huang M; Cao G; Kaz AM; Grady WM; Wang J; Luo Y
    Cancer Res; 2020 Dec; 80(23):5203-5215. PubMed ID: 33051252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.